“Efficacy of Apremilast on Quality-of-Life Measures in Patients with Moderate Plaque Psoriasis (UNVEIL Phase IV Study)”, J of Skin, vol. 1, no. 3.1, p. s13, Oct. 2017, doi: 10.25251/skin.1.supp.12.